← Research hub  ·  securities

GSK · GSK plc (ADR) $50.07 -0.99 (-1.94%) 2026-SEP-18 12:49 EST

My allocationNot heldas of 2026-SEP-03 · allocation page ↗
Research: QT · SA · STK · FA1 mention
2026-AUG-07 · CNBC · CNBC Halftime Report (audio edition) · Neutralmention · read ↗ · source page ↗$52.71

In short: One of Harrington's healthcare holdings read off by Wapner (with Bristol-Myers, Pfizer, Regeneron, Roche, Thermo Fisher and Zimmer): "some of them are up 10% and some are up 23%, but they're all up nicely — so the rebound's already started." No individual call.

SOD $52.71

Nothing matches this filter.

Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.